SCHEMBL18914545

SCHEMBL18914545

CCOC(=O)C1CCCN(c2cc(C(C)C)ccc2CO)C1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.52
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
HPGD P15428 3/20 0.48
TSHR P16473 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
MAPT P10636 2/20 0.48
HSD17B10 Q99714 1/20 0.48
USP2 O75604 1/20 0.48
POLB P06746 1/20 0.48
THRB P10828 1/20 0.48
S100A4 P26447 1/20 0.48
HTT P42858 1/20 0.48
RECQL P46063 1/20 0.48
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23168819 1.00 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL18914677 0.87 LGMN (0.53) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL18914805 0.82 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL23168999 0.82 SHMT2 (0.43) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL3436332 0.74 ALDH1A1 (0.63) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL1197272 0.74 TSHR (0.56) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL1197702 0.74 TSHR (0.56) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL23168880 0.73 MAPT (0.58) ALDH1A1KMT2AMEN1HPGDTSHR
SCHEMBL3436239 0.72 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL21848213 0.72 SHMT2 (0.59) ALDH1A1KMT2AKDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017090743-A1 NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST 田辺三菱製薬株式会社 2017-06-01 WO disclosed